Seven Eight Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-30,297
Closed -$2.57M 647
2018
Q4
$2.57M Buy
+30,297
New +$2.57M 0.14% 195
2018
Q3
Sell
-2,084
Closed -$269K 641
2018
Q2
$269K Buy
+2,084
New +$269K 0.02% 418
2017
Q4
Sell
-2,405
Closed -$204K 522
2017
Q3
$204K Buy
+2,405
New +$204K 0.02% 418